182 related articles for article (PubMed ID: 30122451)
1. A Hotspot for Disease-Associated Variants of Human PGM1 Is Associated with Impaired Ligand Binding and Loop Dynamics.
Stiers KM; Beamer LJ
Structure; 2018 Oct; 26(10):1337-1345.e3. PubMed ID: 30122451
[TBL] [Abstract][Full Text] [Related]
2. Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.
Stiers KM; Owuocha LF; Beamer LJ
Acta Crystallogr F Struct Biol Commun; 2022 May; 78(Pt 5):200-209. PubMed ID: 35506765
[TBL] [Abstract][Full Text] [Related]
3. A missense variant remote from the active site impairs stability of human phosphoglucomutase 1.
Stiers KM; Hansen RP; Daghlas BA; Mason KN; Zhu JS; Jakeman DL; Beamer LJ
J Inherit Metab Dis; 2020 Jul; 43(4):861-870. PubMed ID: 32057119
[TBL] [Abstract][Full Text] [Related]
4. Asp263 missense variants perturb the active site of human phosphoglucomutase 1.
Stiers KM; Graham AC; Kain BN; Beamer LJ
FEBS J; 2017 Mar; 284(6):937-947. PubMed ID: 28117557
[TBL] [Abstract][Full Text] [Related]
5. Induced Structural Disorder as a Molecular Mechanism for Enzyme Dysfunction in Phosphoglucomutase 1 Deficiency.
Stiers KM; Kain BN; Graham AC; Beamer LJ
J Mol Biol; 2016 Apr; 428(8):1493-505. PubMed ID: 26972339
[TBL] [Abstract][Full Text] [Related]
6. Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.
Beamer LJ
J Inherit Metab Dis; 2015 Mar; 38(2):243-56. PubMed ID: 25168163
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.
Backe PH; Laerdahl JK; Kittelsen LS; Dalhus B; Mørkrid L; Bjørås M
Sci Rep; 2020 Mar; 10(1):5656. PubMed ID: 32221390
[TBL] [Abstract][Full Text] [Related]
8. Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.
Beamer LJ
Biochimie; 2021 Apr; 183():44-48. PubMed ID: 32898648
[TBL] [Abstract][Full Text] [Related]
9. Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency.
Lee Y; Stiers KM; Kain BN; Beamer LJ
J Biol Chem; 2014 Nov; 289(46):32010-32019. PubMed ID: 25288802
[TBL] [Abstract][Full Text] [Related]
10. Destabilization and Degradation of a Disease-Linked PGM1 Protein Variant.
Gouliaev F; Jonsson N; Gersing S; Lisby M; Lindorff-Larsen K; Hartmann-Petersen R
Biochemistry; 2024 Jun; 63(11):1423-1433. PubMed ID: 38743592
[No Abstract] [Full Text] [Related]
11. Structure and Characterization of Phosphoglucomutase 5 from Atlantic and Baltic Herring-An Inactive Enzyme with Intact Substrate Binding.
Gustafsson R; Eckhard U; Ye W; Enbody ED; Pettersson M; Jemth P; Andersson L; Selmer M
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287293
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene.
Ding Y; Li N; Chang G; Li J; Yao R; Shen Y; Wang J; Huang X; Wang X
J Pediatr Endocrinol Metab; 2018 Jul; 31(7):781-788. PubMed ID: 29858906
[TBL] [Abstract][Full Text] [Related]
13. Catalytic cycling in beta-phosphoglucomutase: a kinetic and structural analysis.
Zhang G; Dai J; Wang L; Dunaway-Mariano D; Tremblay LW; Allen KN
Biochemistry; 2005 Jul; 44(27):9404-16. PubMed ID: 15996095
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis.
Conte F; Ashikov A; Mijdam R; van de Ven EGP; van Scherpenzeel M; Veizaj R; Mahalleh-Yousefi SP; Post MA; Huijben K; Panneman DM; Rodenburg RJT; Voermans NC; Garanto A; Koopman WJH; Wessels HJCT; Noga MJ; Lefeber DJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175952
[TBL] [Abstract][Full Text] [Related]
15. Biology, Mechanism, and Structure of Enzymes in the α-d-Phosphohexomutase Superfamily.
Stiers KM; Muenks AG; Beamer LJ
Adv Protein Chem Struct Biol; 2017; 109():265-304. PubMed ID: 28683921
[TBL] [Abstract][Full Text] [Related]
16. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
Jin GZ; Zhang Y; Cong WM; Wu X; Wang X; Wu S; Wang S; Zhou W; Yuan S; Gao H; Yu G; Yang W
PLoS Biol; 2018 Oct; 16(10):e2006483. PubMed ID: 30335765
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
[TBL] [Abstract][Full Text] [Related]
18. Phosphoglucomutase1 is necessary for sustained cell growth under repetitive glucose depletion.
Bae E; Kim HE; Koh E; Kim KS
FEBS Lett; 2014 Aug; 588(17):3074-80. PubMed ID: 24952355
[TBL] [Abstract][Full Text] [Related]
19. Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy.
Arimura T; Inagaki N; Hayashi T; Shichi D; Sato A; Hinohara K; Vatta M; Towbin JA; Chikamori T; Yamashina A; Kimura A
Cardiovasc Res; 2009 Jul; 83(1):80-8. PubMed ID: 19377068
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of phosphoglucomutase from Leishmania major at 3.5 Å resolution.
Waugh B; Sen U; Banerjee R
Biochimie; 2016 Feb; 121():102-11. PubMed ID: 26607241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
